SymbolHYPD
NameHYPERION DEFI, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Pharmaceutical Preparations
Address295 MADISON AVENUE,SUITE 2400, NEW YORK, New York, 10017, United States
Telephone+1 917 289-1117
Fax
Email
Websitehttps://www.eyenovia.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001682639
Description

Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

Additional info from NASDAQ:
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.

2026-05-14 11:00

(30% Negative) HYPERION DEFI, INC. (HYPD) Reports Q2 2026 Financial Results

Read more
2026-05-08 11:00

Hyperion DeFi Announces Closing of Public Offering of Common Stock

Read more
2026-05-06 20:05

(99% Neutral) HYPERION DEFI, INC. (HYPD) Announces Business Combination

Read more
2026-05-06 17:03

New Form 424B5 - HYPERION DEFI, INC. <b>Filed:</b> 2026-05-06 <b>AccNo:</b> 0001104659-26-056233 <b>Size:</b> 442 KB

Read more
2026-05-05 20:01

Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Read more
2026-05-05 18:11

New Form DEFA14A - HYPERION DEFI, INC. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001104659-26-055727 <b>Size:</b> 467 KB

Read more
2026-05-05 18:11

New Form DEF 14A - HYPERION DEFI, INC. <b>Filed:</b> 2026-05-05 <b>AccNo:</b> 0001104659-26-055725 <b>Size:</b> 3 MB

Read more
2026-05-01 15:12

Hyperion DeFi Schedules First Quarter Earnings Call for Thursday, May 14 at 8:00 a.m. ET

Read more
2026-04-27 14:50

Hyperion DeFi Announces Participation in Upcoming Investor and Industry Conferences

Read more
2026-04-01 09:33

New Form SCHEDULE 13G/A - HYPERION DEFI, INC. <b>Filed:</b> 2026-04-01 <b>AccNo:</b> 0001104659-26-038248 <b>Size:</b> 6 KB

Read more